AYGEN, B. Et Al. 2019. Ombitasvir/ Paritaprevir/ Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience. Infectious Diseases and Clinical Microbiology , vol.1, no.2 , 97-106.

AYGEN, B., DEMİRTÜRK, N., YILDIZ, O., Celik, I., Kamalak Güzel, D., ERSÖZ, G., ... BATIREL, A.(2019). Ombitasvir/ Paritaprevir/ Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience. Infectious Diseases and Clinical Microbiology , vol.1, no.2, 97-106.

AYGEN, BİLGEHAN Et Al. "Ombitasvir/ Paritaprevir/ Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience," Infectious Diseases and Clinical Microbiology , vol.1, no.2, 97-106, 2019

AYGEN, BİLGEHAN Et Al. "Ombitasvir/ Paritaprevir/ Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience." Infectious Diseases and Clinical Microbiology , vol.1, no.2, pp.97-106, 2019

AYGEN, B. Et Al. (2019) . "Ombitasvir/ Paritaprevir/ Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience." Infectious Diseases and Clinical Microbiology , vol.1, no.2, pp.97-106.

@article{article, author={BİLGEHAN AYGEN Et Al. }, title={Ombitasvir/ Paritaprevir/ Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience}, journal={Infectious Diseases and Clinical Microbiology}, year=2019, pages={97-106} }